Our process development platform is defined and designed to ensure scale up directly from bench scale to clinical batch manufacturing in a timely manner. From DNA to IND, we can achieve it in as short as 12 months.

• Dedicated 200 to 500L production bioreactors
• Single use technology
• Flexible platforms from Cytiva, Thermo Fisher, and Sartorius
• GMP ready

CLB 12-month DNA to IND program